The Ocular Surface Disease Index (OSDI) and Standard Patient Evaluation of Eye Dryness (SPEED) questionnaires showed moderate correlation but poor agreement in patients with dry eye disease, suggesting they should...

According to a Phase 3 noninferiority trial, 5% diquafosol eye drops demonstrate comparable efficacy and tolerability to 3% diquafosol for dry eye disease with a reduced dosing schedule. The double-blind,...

Topical azithromycin ophthalmic solution (Azyter, 15 mg/g) significantly improved disease symptoms and signs as second-line treatment for mixed dry eye disease (DED), according to a study. The prospective controlled pilot...